Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Hill-Rom stock

Learn how to easily invest in Hill-Rom stock.

Hill-Rom Holdings Inc is a medical instruments & supplies business based in the US. Hill-Rom shares (HRC) are listed on the NYSE and all prices are listed in US Dollars. Hill-Rom employs 10,000 staff and has a trailing 12-month revenue of around $3 billion.

How to buy shares in Hill-Rom

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HRC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Hill-Rom stock price (NYSE: HRC)

Use our graph to track the performance of HRC stocks over time.

Hill-Rom shares at a glance

Information last updated 2022-02-06.
Latest market close$155.96
52-week range$149.20 - $156.22
50-day moving average $154.34
200-day moving average $130.22
Wall St. target price$156.00
PE ratio 41.9247
Dividend yield $0.94 (0.62%)
Earnings per share (TTM) $3.72

Buy Hill-Rom shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Hill-Rom stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hill-Rom price performance over time

Historical closes compared with the close of $155.96 from 2021-12-13

1 week (2022-09-19) N/A
1 month (2022-08-26) N/A
3 months (2022-06-26) N/A
6 months (2022-03-26) N/A
1 year (2021-09-30) 3.97%
2 years (2020-09-30) 86.76%
3 years (2019-09-30) 48.21%
5 years (2017-09-29) 110.76%

Is Hill-Rom stock undervalued or overvalued?

Valuing Hill-Rom stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hill-Rom's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hill-Rom's P/E ratio

Hill-Rom's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Hill-Rom shares trade at around 42x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Hill-Rom's PEG ratio

Hill-Rom's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hill-Rom's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hill-Rom's EBITDA

Hill-Rom's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $645.3 million.

The EBITDA is a measure of a Hill-Rom's overall financial performance and is widely used to measure a its profitability.

Hill-Rom financials

Revenue TTM $3 billion
Operating margin TTM 15.7%
Gross profit TTM $1.6 billion
Return on assets TTM 6.13%
Return on equity TTM 13.78%
Profit margin 8.23%
Book value $28.53
Market capitalisation $10.3 billion

TTM: trailing 12 months

Hill-Rom share dividends


Dividend payout ratio: 15.21% of net profits

Recently Hill-Rom has paid out, on average, around 15.21% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.62% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Hill-Rom shareholders could enjoy a 0.62% return on their shares, in the form of dividend payments. In Hill-Rom's case, that would currently equate to about $0.94 per share.

While Hill-Rom's payout ratio might seem low, this can signify that Hill-Rom is investing more in its future growth.

Hill-Rom's most recent dividend payout was on 30 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").

Have Hill-Rom's shares ever split?

Hill-Rom's shares were split on a 2:1 basis on 1 March 1992. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hill-Rom shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hill-Rom shares which in turn could have impacted Hill-Rom's share price.

Hill-Rom share price volatility

Over the last 12 months, Hill-Rom's shares have ranged in value from as little as $149.2 up to $156.22. A popular way to gauge a stock's volatility is its "beta".

HRC.US volatility(beta: 0.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Hill-Rom's is 0.5532. This would suggest that Hill-Rom's shares are less volatile than average (for this exchange).

Hill-Rom overview

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. The company also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, it offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, the company sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors.

Frequently asked questions

What percentage of Hill-Rom is owned by insiders or institutions?
Currently 0.18% of Hill-Rom shares are held by insiders and 84.381% by institutions.
How many people work for Hill-Rom?
Latest data suggests 10,000 work at Hill-Rom.
When does the fiscal year end for Hill-Rom?
Hill-Rom's fiscal year ends in September.
Where is Hill-Rom based?
Hill-Rom's address is: 130 East Randolph Street, Chicago, IL, United States, 60601
What is Hill-Rom's ISIN number?
Hill-Rom's international securities identification number is: US4314751029
What is Hill-Rom's CUSIP number?
Hill-Rom's Committee on Uniform Securities Identification Procedures number is: 431475102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site